Literature DB >> 33227640

Poly-prescription drug misuse across the life course: Prevalence and correlates across different adult age cohorts in the U.S.

Jason A Ford1, Ty S Schepis2, Sean Esteban McCabe3.   

Abstract

BACKGROUND: Most research on prescription drug misuse (PDM) focuses on the misuse of specific classes of psychoactive prescription drugs among adolescents or young adults. The current research addressed important gaps in the literature by assessing poly-prescription drug misuse (poly-PDM), the misuse of more than one class of psychoactive prescription drug, across different adult age cohorts.
METHODS: We used the 2015-2018 National Survey on Drug Use and Health to examine the prevalence of past-year poly-PDM and specific combinations of PDM. Multinomial logistic regression was used to identify demographic, health-related factors, and substance use behaviors that were significantly associated with poly-PDM.
RESULTS: The prevalence of poly-PDM decreases with age and is common among individuals who engage in PDM. Slightly more than one in four respondents in age cohorts 18-25 (31.66%, 95% CI = 30.35, 33.00) and 26-34 (29.92%, 95% CI = 25.82, 30.12) who engage in PDM, misused more than one class of prescription drug. Additionally, poly-PDM was identified as a high-risk type of PDM as roughly 60% of adults younger than 65 who endorse poly-PDM reported having a substance use disorder (SUD). While certain characteristics (i.e., race/ethnicity, marital status, depression, suicidal ideation, illegal drug use, and SUD) were consistently associated with poly-PDM across age cohorts, other characteristics (i.e., sexual identity, income, and justice involvement) varied across age cohorts. Finally, a comparison of poly-PDM to single PDM showed, in all age cohorts, that having an SUD was associated with an increased likelihood of poly-PDM, while Black adults were less likely than whites to report poly-PDM.
CONCLUSIONS: By identifying prevalence and correlates of poly-PDM across adult age cohorts, the current research has significant implications. Understanding stability and heterogeneity in the characteristics associated with poly-PDM should inform interventions, identify at-risk groups, and shape public health approaches to dealing with high-risk substance use behavior.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Life course; Polysubstance use; Prescription drug misuse

Mesh:

Substances:

Year:  2020        PMID: 33227640      PMCID: PMC8005409          DOI: 10.1016/j.drugpo.2020.103017

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  71 in total

1.  Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates.

Authors:  William C Becker; Lynn E Sullivan; Jeanette M Tetrault; Rani A Desai; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2007-12-11       Impact factor: 4.492

2.  Prevalence and Correlates of Prescription Stimulant Use, Misuse, Use Disorders, and Motivations for Misuse Among Adults in the United States.

Authors:  Wilson M Compton; Beth Han; Carlos Blanco; Kimberly Johnson; Christopher M Jones
Journal:  Am J Psychiatry       Date:  2018-04-16       Impact factor: 18.112

3.  Multiple DSM-5 substance use disorders: A national study of US adults.

Authors:  Sean Esteban McCabe; Brady T West; Emily M Jutkiewicz; Carol J Boyd
Journal:  Hum Psychopharmacol       Date:  2017-07-27       Impact factor: 1.672

4.  The U.S. opioid epidemic: One disease, diverging tales.

Authors:  Ryan McBain; Adam J Rose; Marc R LaRochelle
Journal:  Prev Med       Date:  2018-04-21       Impact factor: 4.018

5.  Effect of Age on Opioid Prescribing, Overdose, and Mortality in Massachusetts, 2011 to 2015.

Authors:  Adam J Rose; Ryan McBain; Megan S Schuler; Marc R LaRochelle; David A Ganz; Vikram Kilambi; Bradley D Stein; Dana Bernson; Kenneth Kwan Ho Chui; Thomas Land; Alexander Y Walley; Thomas J Stopka
Journal:  J Am Geriatr Soc       Date:  2018-11-24       Impact factor: 5.562

6.  Polydrug use patterns and their impact on relapse among heroin-dependent patients in Shanghai, China.

Authors:  Tianzhen Chen; Na Zhong; Jiang Du; Zhibin Li; Yan Zhao; Haiming Sun; Zhikang Chen; Haifeng Jiang; Min Zhao
Journal:  Addiction       Date:  2018-10-31       Impact factor: 6.526

7.  Medical and nonmedical use of prescription sedatives and anxiolytics: Adolescents' use and substance use disorder symptoms in adulthood.

Authors:  Sean Esteban McCabe; Philip Veliz; Carol J Boyd; John E Schulenberg
Journal:  Addict Behav       Date:  2016-08-15       Impact factor: 3.913

8.  Trends and correlates of substance use disorders among probationers and parolees in the United States 2002-2014.

Authors:  Noelle E Fearn; Michael G Vaughn; Erik J Nelson; Christopher P Salas-Wright; Matt DeLisi; Zhengmin Qian
Journal:  Drug Alcohol Depend       Date:  2016-08-05       Impact factor: 4.492

9.  The crossover effect: A review of racial/ethnic variations in risk for substance use and substance use disorder across development.

Authors:  Devin E Banks; Tamika C B Zapolski
Journal:  Curr Addict Rep       Date:  2018-07-13

10.  How Frequently are "Classic" Drug-Seeking Behaviors Used by Drug-Seeking Patients in the Emergency Department?

Authors:  Casey A Grover; Joshua W Elder; Reb Jh Close; Sean M Curry
Journal:  West J Emerg Med       Date:  2012-11
View more
  2 in total

1.  Stressful life events and prescription opioid use during pregnancy: findings from the 2019 pregnancy risk assessment monitoring system.

Authors:  Alexander Testa; Allison D Crawford; Dylan B Jackson; Alison Gemmill
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-08-10       Impact factor: 4.519

2.  Gender-specific correlates of nonmedical use of prescription medications in a diverse primary care sample.

Authors:  Taylor B Crouch; Caitlin E Martin; Kathryn Polak; Wally Smith; Pamela Dillon; Steve Ondersma; Dace Svikis
Journal:  Drug Alcohol Depend       Date:  2022-03-08       Impact factor: 4.852

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.